TABLE 4.
Parameter | Value for group |
P value | |
---|---|---|---|
Active TB (n = 17) | Latent TB (n = 26) | ||
Median % of CD4 cells (25th–75th percentile) | |||
CD154+ TNF-α+ GM-CSF+ | 0.004 (0.002–0.015) | 0.017 (0.013–0.045) | <0.001 |
CD154+ TNF-α+ IL-2+ | 0.013 (0.005–0.035) | 0.042 (0.024–0.077) | <0.001 |
CD154+ TNF-α+ IFN-γ− IL-2− | 0.013 (0.002–0.021) | 0.014 (0.007–0.026) | 0.148 |
CD154+ TNF-α+ CD27− | 0.014 (0.006–0.035) | 0.029 (0.016–0.063) | 0.101 |
CD154+ TNF-α+ IFN-γ+ CD27− | 0.011 (0.003–0.023) | 0.020 (0.012–0.042) | 0.030 |
CD154+ TNF-α+ GM-CSF+ CD27− | 0.003 (0.001–0.011) | 0.010 (0.003–0.017) | 0.041 |
CD154+ TNF-α+ IL-2+ CD27− | 0.007 (0.003–0.017) | 0.015 (0.007–0.033) | 0.031 |
Median % of CD4+ TNF-α+ CD154+ cells (25th–75th percentile) | |||
IFN-γ+ | 56.0 (37.0–64.0) | 67.0 (62.0–76.0) | 0.001 |
GM-CSF+ | 24.0 (11.2–32.5) | 28.0 (22.0–39.0) | 0.065 |
IL-2+ | 47.0 (32.0–59.0) | 61.0 (45.0–73.0) | 0.021 |
IL-17A+ | 5.0 (2.0–10.0) | 2.0 (1.0–3.0) | 0.024 |
IL-22+ | 2.5 (0.7–8.3) | 1.5 (0.0–2.3) | 0.132 |
IL-2− IFN-γ− | 29.0 (20.0–47.0) | 21.0 (15.0–30.0) | 0.044 |
IL-2+ IFN-γ+ | 30.0 (16.0–38.5) | 50.0 (30.0–60.0) | 0.001 |
CXCR3+ | 12.7 (2.5–18.0) | 17.7 (8.0–26.0) | 0.072 |
Median % of CD4+ TNF-α+ CD154+ CD27− cells (25th–75th percentile) | |||
Total | 61.0 (47.0–68.0) | 42.0 (36.0–53.0) | 0.009 |
IFN-γ+ | 70.0 (49.0–76.5) | 44.0 (33.0–55.0) | 0.016 |
GM-CSF+ | 66.5 (48.5–78.8) | 40.0 (29.0–51.0) | 0.002 |
IL-2+ | 53.0 (44.0–66.5) | 38.0 (30.0–44.0) | 0.003 |
Median absolute no. of cells/ml (25th–75th percentile) | |||
CD4+ TNF-α+ CD154+ IFN-γ− IL-2− | 71 (12–146) | 82 (48–236) | 0.130 |
CD4+ TNF-α+ CD154+ CD27− | 101 (36–293) | 190 (115–438) | 0.109 |
CD4+ TNF-α+ CD154+ IFN-γ+ CD27− | 58 (14–221) | 135 (84–332) | 0.055 |
CD4+ TNF-α+ CD154+ GM-CSF+ CD27− | 15 (6–71) | 59 (25–106) | 0.025 |
CD4+ TNF-α+ CD154+ IL-2+ CD27− | 45 (15–128) | 110 (59–174) | 0.043 |
Results for Mann-Whitney U test comparisons between the active and latent TB groups are displayed.